Jays' Hollon, Twins' Lombana suspended
NEW YORK -- Blue Jays No. 11 prospect Clinton Hollon and Twins righty Logan Lombana were suspended Tuesday after both tested positive for a banned substance.
The Office of the Commissioner of Baseball said Hollon received a 50-game suspension without pay following a second positive test for a drug of abuse, while Lombana received an 80-game suspension without pay after testing positive for Ibutamoren, a performance-enhancing substance in violation of the Minor League Drug Prevention and Treatment Program.
Hollon went 3-3 with a 3.38 ERA in a dozen starts last year between Class A Lansing and Class A Short Season Vancouver before earning a 50-game suspension for amphetamines on Aug. 21. The 21-year-old is 4-4 with a 3.32 ERA in 18 career Minor League games since the Blue Jays selected him in the second round of the 2013 Draft out of Woodford County High School in Kentucky.
Lombana, Minnesota's 25th-round pick last summer out of Long Beach State, owned a 3.38 ERA in seven relief appearances for Class A Cedar Rapids this season. He's struck out 16 and walked five in 16 innings in the Midwest League after spending 15 games with Rookie-level Elizabethton last year.
Substances considered "drugs of abuse" under the Minor League drug program include any Schedule I and II controlled substance in the U.S. That list includes marijuana, synthetic THC, cocaine, MDA, Ecstasy, opiates like heroin and morphine and other drugs like "bath salts," LSD and PCP. Players who test positive for a drug of abuse are given a warning and must have a follow-up test, while a second violation results in a 50-game suspension.
Major League Baseball has suspended 43 players this year for a combined 2,820 games for violations of the Minor League drug program.
Danny Wild is an editor for MiLB.com. Follow his MLBlog column, Minoring in Twitter.